WONG TEEK SON
Executive Chairman & Chief Executive Officer
Board of DirectorsThe business, the people and the ownership behind Riverstone.
Business overview
Riverstone Holdings manufactures cleanroom and healthcare gloves, finger cots, cleanroom packaging bags and face masks. Its products serve electronics and healthcare customers internationally, supported by manufacturing facilities in Asia.
Listed security
Board & management
Nine director profiles include two alternate directors. Wong Teek Son is Executive Chairman and Chief Executive Officer. Dumrongsak Aroonprasertkul was appointed on 16 July 2025.
Executive Chairman & Chief Executive Officer
Board of DirectorsExecutive Director & Chief Operating Officer
Board of DirectorsAlternate Director of Mr Wong Teek Son
Board of DirectorsAlternate Director of Mr Lee Wai Keong
Board of DirectorsNon-Independent Non-Executive Director
Board of Directorsappointed to the Board as a Non-Independent Non-Executive Director on 16 July 2025
in-year appointmentLead Independent Non-Executive Director
Board of DirectorsIndependent Non-Executive Director
Board of DirectorsIndependent Non-Executive Director
Board of DirectorsIndependent Non-Executive Director
Board of DirectorsRoles listed in ANNUAL REPORT 2025; current appointments are not independently verified.
Holdings
Top 20 registered holders and substantial shareholders are dated 9 March 2026. Registered holdings sum to the printed 1,335,810,195 shares. Registered nominees and direct/deemed interests overlap and must not be added.
Director-interest columns compare 1 January 2025 or date of appointment with 31 December 2025; no change is stated up to 21 January 2026. Superscripts are source explanatory notes, separate from percentage values.
Direct interest: 8,868,000 shares (0.59%); deemed interest: 753,633,120 shares (50.85%).
Substantial shareholders; direct and deemed interests As reported at 2026-03-09Direct interest: 753,633,120 shares (50.85%).
Substantial shareholders; direct interest As reported at 2026-03-09Direct interest: 753,633,120 shares (50.85%).
Substantial shareholders; direct interest As reported at 2026-03-09Direct interest: 130,791,600 shares (8.82%).
Substantial shareholders; direct interest As reported at 2026-03-09Direct at 1 January 2025 or date of appointment: 8,868,000; direct at 31 December 2025: 8,868,000; deemed at 1 January 2025 or date of appointment: 752,133,120*; deemed at 31 December 2025: 753,633,120* shares.
Ordinary shares of the Company; register of director shareholdingsDirect at 1 January 2025 or date of appointment: 130,791,600; direct at 31 December 2025: 130,791,600; deemed at 1 January 2025 or date of appointment: –; deemed at 31 December 2025: – shares.
Ordinary shares of the Company; register of director shareholdingsDirect at 1 January 2025 or date of appointment: 196,000; direct at 31 December 2025: 196,000; deemed at 1 January 2025 or date of appointment: 72,000**; deemed at 31 December 2025: 72,000** shares.
Ordinary shares of the Company; register of director shareholdingsDirect at 1 January 2025 or date of appointment: 260,000; direct at 31 December 2025: 260,000; deemed at 1 January 2025 or date of appointment: –; deemed at 31 December 2025: – shares.
Ordinary shares of the Company; register of director shareholdingsDirect at 1 January 2025 or date of appointment: 1,205,000; direct at 31 December 2025: 1,205,000; deemed at 1 January 2025 or date of appointment: –; deemed at 31 December 2025: – shares.
Ordinary shares of the Company; register of director shareholdingsDirect at 1 January 2025 or date of appointment: 3,180,000; direct at 31 December 2025: 3,180,000; deemed at 1 January 2025 or date of appointment: –; deemed at 31 December 2025: – shares.
Ordinary shares of the Company; register of director shareholdingsApproximately 36.51% of issued shares excluding treasury shares held by the public
as at 9 March 2026 As reported at 2026-03-092,736,000 treasury shares representing 0.185% of total issued shares excluding treasury shares
as at 9 March 2026 As reported at 2026-03-09There was no change in any of the above-mentioned interests in the Company between the end of the financial year and 21 January 2026.
Directors’ shareholdings after year end As reported at 2026-01-21There were no share options granted during the financial year to subscribe for unissued shares of the Company.
CompanyThere were no shares issued during the financial year by virtue of the exercise of options to take up unissued shares.
CompanyAt the end of the financial year, there were no unissued shares of the Company under option.
CompanyTotal interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-03-09 · PDF p. 97
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| CITIBANK NOMINEES SINGAPORE PTE LTD | 506,904,536 shares; 34.20%. | PDF p. 972026-03-09 | |
| DBSN SERVICES PTE. LTD. | 197,010,668 shares; 13.29%. | PDF p. 972026-03-09 | |
| DBS NOMINEES (PRIVATE) LIMITED | 163,261,557 shares; 11.02%. | PDF p. 972026-03-09 | |
| LEE WAI KEONG | 130,791,600 shares; 8.82%. | PDF p. 972026-03-09 | |
| RAFFLES NOMINEES (PTE.) LIMITED | 102,461,939 shares; 6.91%. | PDF p. 972026-03-09 | |
| HSBC (SINGAPORE) NOMINEES PTE LTD | 58,229,108 shares; 3.93%. | PDF p. 972026-03-09 | |
| WONG TECK CHOON | 42,809,920 shares; 2.89%. | PDF p. 972026-03-09 | |
| BPSS NOMINEES SINGAPORE (PTE.) LTD. | 41,494,164 shares; 2.80%. | PDF p. 972026-03-09 | |
| BNP PARIBAS NOMINEES SINGAPORE PTE. LTD. | 18,093,100 shares; 1.22%. | PDF p. 972026-03-09 | |
| PHILLIP SECURITIES PTE LTD | 13,748,178 shares; 0.93%. | PDF p. 972026-03-09 | |
| IFAST FINANCIAL PTE. LTD. | 9,183,336 shares; 0.62%. | PDF p. 972026-03-09 | |
| CHEE TING TUAN | 8,700,000 shares; 0.59%. | PDF p. 972026-03-09 | |
| SAN TAI CONSTRUCTION (S) PTE LTD | 7,000,000 shares; 0.47%. | PDF p. 972026-03-09 | |
| UNITED OVERSEAS BANK NOMINEES (PRIVATE) LIMITED | 5,907,880 shares; 0.40%. | PDF p. 972026-03-09 | |
| UOB KAY HIAN PRIVATE LIMITED | 5,859,700 shares; 0.40%. | PDF p. 972026-03-09 | |
| OCBC SECURITIES PRIVATE LIMITED | 5,839,572 shares; 0.39%. | PDF p. 972026-03-09 | |
| MOOMOO FINANCIAL SINGAPORE PTE. LTD. | 4,870,017 shares; 0.33%. | PDF p. 972026-03-09 | |
| CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD. | 4,673,380 shares; 0.32%. | PDF p. 972026-03-09 | |
| LAM YOON CHAN | 4,580,800 shares; 0.31%. | PDF p. 972026-03-09 | |
| MAYBANK SECURITIES PTE. LTD. | 4,390,740 shares; 0.30%. | PDF p. 972026-03-09 | |
Group structure
Eight named subsidiaries are disclosed with effective Group interests for 2025 and 2024. Wuxi is held by Riverstone Resources Sdn Bhd; Shenzhen is held by Eco Medi Glove Sdn Bhd. No named associates/joint-venture schedule is disclosed.
Audit markers (1)–(5) are auditor notes, separate from legal names or ownership percentages. Investment-cost dashes with # denote less than RM500.
| Company | Market | Ownership interest |
|---|---|---|
| Riverstone Resources Sdn BhdGroup interest columns 2025 and 2024; cost of investment columns RM’000 2025 and 2024PDF p. 73 | Malaysia; manufacturer and distributor of examination gloves, cleanroom gloves and finger cots; effective Group equity interests: 2025 100%; 2024 100% | |
| Riverstone Cleanroom Products Sdn BhdGroup interest columns 2025 and 2024; cost of investment columns RM’000 2025 and 2024PDF p. 73 | Malaysia; manufacturer of plastic bags and trader in latex products; effective Group equity interests: 2025 100%; 2024 100% | |
| Eco Medi Glove Sdn BhdGroup interest columns 2025 and 2024; cost of investment columns RM’000 2025 and 2024PDF p. 73 | Malaysia; manufacturer and distributor of examination gloves, cleanroom gloves and finger cots; effective Group equity interests: 2025 100%; 2024 100% | |
| Eco Star Glove Sdn BhdGroup interest columns 2025 and 2024; cost of investment columns RM’000 2025 and 2024PDF p. 73 | Malaysia; manufacturer and distributor of examination gloves, cleanroom gloves and finger cots; effective Group equity interests: 2025 100%; 2024 100% | |
| Protective Technology Co. LtdGroup interest columns 2025 and 2024; cost of investment columns RM’000 2025 and 2024PDF p. 73 | Thailand; manufacturer and distributor of cleanroom gloves; effective Group equity interests: 2025 99.99%; 2024 99.99% | |
| Riverstone Resources (S) Pte LtdGroup interest columns 2025 and 2024; cost of investment columns RM’000 2025 and 2024PDF p. 73 | Singapore; distributor of cleanroom products; effective Group equity interests: 2025 100%; 2024 100% | |
| Riverstone Resources (Wuxi) Co. LtdGroup interest columns 2025 and 2024; cost of investment columns RM’000 2025 and 2024PDF p. 74 | People’s Republic of China; processing and packing of cleanroom gloves; effective Group equity interests: 2025 100%; 2024 100%; held by Riverstone Resources Sdn Bhd | |
| Eco Medi Glove Products (Shenzhen) Co. LtdGroup interest columns 2025 and 2024; cost of investment columns RM’000 2025 and 2024PDF p. 74 | People’s Republic of China; distributor of cleanroom and medical glove products; effective Group equity interests: 2025 100%; 2024 100%; held by Eco Medi Glove Sdn Bhd | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Tan Wang Thing | Chief Financial Officer | Executive Management | PDF p. 16 |
| Lim Sing Poew | Group General Manager | Executive Management | PDF p. 16 |
Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Hoe Hup Heng Engineering | S$185,825 | Aggregate value of all interested person transactions during FY2025 (excluding transactions less than S$100,000 and transactions under shareholders' mandate pursuant to Rule 920) | PDF p. 43 |
| Hoe Hup Heng Engineering | RM608,800 | Printed RM equivalent of the FY2025 aggregate IPT value | PDF p. 43 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Contingencies | RM127,000,000 | Company; guarantees for forward currency contracts and banking facilities taken by subsidiaries; 2024: RM127,000,000 · As at 2025-12-31 | PDF p. 84 |
| Acquisition of property, plant and equipment | 2,174 RM'000 | Group, 2025 (2024: 17,333) · As at 2025-12-31 | PDF p. 84 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Wong Teek Son | 187 (100%) | FY2025 total remuneration, S$'000 | PDF p. 33 |
| Lee Wai Keong | 516 (100%) | FY2025 total remuneration, S$'000 | PDF p. 33 |
| Lim Jun Xiong Steven | 96 (100%) | FY2025 total remuneration, S$'000 | PDF p. 33 |
| Raymond Fam Chye Soon | 80 (100%) | FY2025 total remuneration, S$'000 | PDF p. 33 |
| Yoong Kah Yin | 80 (100%) | FY2025 total remuneration, S$'000 | PDF p. 33 |
| Charmaine Chee Ying Min | 80 (100%) | FY2025 total remuneration, S$'000 | PDF p. 33 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Business Outlook and Strategy | 2026 remains a challenging year. | Executive Chairman and CEO letter to shareholders | PDF p. 10 |
Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.
Corporate information